BAD Cancer Research Results

BAD, BCL2 associated agonist of cell death: Click to Expand ⟱
Source:
Type:
BCL2 associated agonist of cell death (BAD) protein is a pro-apoptotic member of the Bcl-2 gene family.
Expression of the BAD is associated with the development and progression of cancer.
Scientific Papers found: Click to Expand⟱
8898- MOR,    Molecular mechanism of anti-cancerous potential of Morin extracted from mulberry in Hela cells
- in-vitro, Cerv, HeLa
TumCP↓, TumCCA↑, Apoptosis↑, P53↑, P21↑, WEE1↑, CDK1↓, CDC25↓, survivin↓, CycB/CCNB1↓, Chk2↓, BAX↑, BAD↑, Cyt‑c↑, APAF1↑, Casp9↑, TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, DR5↑, FasL↑, FADD↑, Casp10↑, PARP↑, PI3K↑, Akt↑, mTOR↑, p70S6↑, Diablo↑, Bcl-2↓, Bcl-xL↓, AMPK↓, IAP1↓, NF-kB↓, ROS↑,
8954- mushLions,    Hericium erinaceus polysaccharide-protein HEG-5 inhibits SGC-7901 cell growth via cell cycle arrest and apoptosis
- in-vitro, GC, SGC-7901
TumCP↓, Tumccf↓, Apoptosis↑, TumCCA↑, Bcl-2↓, PI3K↓, Akt↓, Casp8↑, Casp3↑, P53↑, CDK4↑, BAX↑, BAD↑, ROS↑,
6491- Nimb,    Nanodelivery and anticancer effect of a limonoid, nimbolide, in breast and pancreatic cancer cells
- Review, PC, NA
eff↑, uPA↓, uPAR↓, p‑EGFR↓, VEGFR1↓, NF-kB↓, IKKα↓, MMP2↓, MMP9↓, TIMP2↑, TumCP↓, IGFR↓, Akt↓, ERK↓, TumCCA↓, BAX↑, BAD↑, FasL⇅, Cyt‑c↑, EPR↑,
4643- OLE,  HT,    Use of Oleuropein and Hydroxytyrosol for Cancer Prevention and Treatment: Considerations about How Bioavailability and Metabolism Impact Their Adoption in Clinical Routine
- Review, Var, NA
TumCCA↑, Apoptosis↑, ER Stress↑, UPR↑, CHOP/DDIT3↑, ROS↑, Bcl-2↓, NOX4↑, Hif1a↓, MMP2↓, MMP↓, VEGF↓, Akt↓, NF-kB↓, p65↓, SIRT3↓, mTOR↓, Catalase↓, SOD2↓, FASN↓, STAT3↓, HDAC2↓, HDAC3↓, BAD↑, BAX↑, Bak↑, Casp3↑, Casp9↑, PARP↑, P53↑, P21↑, p27/CDKN1B↑, Half-Life↝, BioAv↓, BioAv↓, selectivity↑, RadioS↑, *ROS↓, *GSH↑, *MDA↓, *SOD↑, *Catalase↑, *NRF2↑, *chemoP↑, *Inflam↓, PPARγ↑,
5218- PG,    Propyl gallate inhibits hepatocellular carcinoma cell growth through the induction of ROS and the activation of autophagy
- in-vitro, HCC, Hep3B
TumCP↓, Apoptosis↑, ROS↑, TumAuto↑, cl‑Casp3↑, cl‑PARP↑, BAX↑, BAD↑, Bcl-2↓, toxicity↓, hepatoP↑, GSH↓,
5208- PI,    Piperine Inhibits Cell Proliferation and Induces Apoptosis of Human Gastric Cancer Cells by Downregulating Phosphatidylinositol 3-Kinase (PI3K)/Akt Pathway
- in-vitro, GC, SNU16 - in-vitro, Nor, GES-1
TumCP↓, Apoptosis↑, BAX↑, BAD↑, Cyt‑c↑, cl‑PARP↑, cl‑Casp3↑, Bcl-2↓, Bcl-xL↓, p‑PI3K↓, p‑Akt↓, Ki-67↓, toxicity↓, RadioS↑,
71- QC,    Role of Bax in quercetin-induced apoptosis in human prostate cancer cells
- in-vitro, Pca, LNCaP - in-vitro, Pca, PrEC - in-vitro, Pca, YPEN-1 - in-vitro, Pca, HCT116
Casp8↑, Casp9↑, PARP↑, BAD↓, BAX↑, PI3K/Akt↓, Cyt‑c↑, selectivity↑,
86- QC,  PacT,    Quercetin regulates insulin like growth factor signaling and induces intrinsic and extrinsic pathway mediated apoptosis in androgen independent prostate cancer cells (PC-3)
- vitro+vivo, Pca, PC3
BAD↑, IGFBP3↑, Cyt‑c↑, cl‑Casp9↑, Casp10↑, cl‑PARP↑, Casp3↑, IGF-1R↓, PI3K↓, p‑Akt↓, cycD1/CCND1↓, IGF-1↓, IGF-2↓, IGF-1R↓, MMP↓, Apoptosis↑, NA?,
82- QC,  ATG,    Arctigenin in combination with quercetin synergistically enhances the anti-proliferative effect in prostate cancer cells
- in-vitro, Pca, LNCaP
AR↓, PI3K/Akt↓, miR-21↓, STAT3↓, BAD↓, PRAS40↓, GSK‐3β↓, PSA↓, NKX3.1↑, Bax:Bcl2↑, miR-19b↓, miR-148a↓, AMPKα↓, TumCP↓, chemoPv↑, TumCMig↓,
6451- SAO,    α-Santalol functionalized chitosan nanoparticles as efficient inhibitors of polo-like kinase in triple negative breast cancer
- vitro+vivo, BC, MDA-MB-231
TumCP↓, selectivity↑, Bcl-2↓, PLK1↓, BAD↑, Casp↑, BAX↑, Dose↝, TumCG↓,
5080- SSE,    Sodium Selenite Regulates the Proliferation and Apoptosis of Gastric Cancer Cells by Suppressing the Expression of LncRNA HOXB-AS1
- in-vitro, GC, HGC27 - in-vitro, GC, NCI-N87
AntiTum↑, HOXB-AS1↓, TumCP↓, TumCI↓, Apoptosis↑, BAD↓, Bcl-2↓, cl‑Casp3↑, MMP2↓, E-cadherin↑, N-cadherin↓, ROS↑, NF-kB↓,
5327- TFdiG,    Theaflavin-3, 3'-digallate induces apoptosis and G2 cell cycle arrest through the Akt/MDM2/p53 pathway in cisplatin-resistant ovarian cancer A2780/CP70 cells
- in-vitro, Ovarian, A2780S
TumCG↓, selectivity↑, TumCCA↑, Apoptosis↑, P53↑, BAX↑, BAD↑, cl‑Casp3↑, p‑Akt↓, MDM2↓, MMP↓, Cyt‑c↑,
2454- Trip,    Natural product triptolide induces GSDME-mediated pyroptosis in head and neck cancer through suppressing mitochondrial hexokinase-ΙΙ
- in-vitro, HNSCC, HaCaT - in-vivo, NA, NA
GSDME-N↑, Pyro↑, cMyc↓, HK2↓, BAD↑, BAX↑, Casp3↑, NRF2↓, xCT/SLC7A11↓, ROS↑, Synergy↑, Glycolysis↓, GlucoseCon↓, lactateProd↓, ATP↓, xCT/SLC7A11↓, eff↑,

Showing Research Papers: 51 to 63 of 63
Prev Page 2 of 2

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 63

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

NA⇅, 1,   NA?, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

Catalase↓, 2,   GPx1↓, 1,   GPx4↓, 1,   GSH↓, 3,   GSH↑, 1,   GSTs↓, 1,   HO-1↑, 1,   NOX4↑, 1,   NRF2↓, 2,   ROS↓, 1,   ROS↑, 32,   SOD↓, 2,   SOD2↓, 1,   TAC↓, 1,   Thiols↓, 1,   TrxR↓, 1,   TrxR1↓, 1,   xCT/SLC7A11↓, 2,  

Metal & Cofactor Biology(tgid=2) ⓘ

IronCh↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

CDC2↓, 2,   CDC25↓, 4,   EGF↓, 2,   mtDam↑, 3,   OCR↓, 1,   SIRT3↓, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

12LOX↓, 1,   ACC↑, 3,   AMPK↓, 1,   AMPK↑, 4,   ATP↓, 2,   FASN↓, 1,   GlucoseCon↓, 2,   Glycolysis↓, 3,   GSK‐3β↓, 1,   GSK‐3β↑, 2,   p‑GSK‐3β↓, 1,   HK2↓, 2,   lactateProd↓, 3,   LDL↓, 1,   p‑PCK1↓, 1,   PDK1 / PDPK1↓, 4,   PFK↓, 1,   PKM2∅, 1,   SIRT1↑, 1,  

Cell Death(tgid=5) ⓘ

14-3-3 proteins↓, 1,   APAF1↑, 5,   Apoptosis↓, 2,   Apoptosis↑, 26,   mt-Apoptosis↑, 2,   BAD?, 1,   BAD↓, 11,   BAD↑, 45,   BAD↝, 1,   p‑BAD↓, 3,   Bak↑, 7,   BAX↑, 34,   BAX↝, 1,   Bax:Bcl2↑, 3,   Bcl-2↓, 31,   Bcl-xL↓, 16,   Bcl-xL↑, 1,   BID↓, 1,   BID↑, 3,   BIM↑, 3,   BOK↑, 2,   Casp↑, 4,   Casp10↑, 3,   cl‑Casp12↑, 1,   Casp3↓, 1,   Casp3↑, 27,   cl‑Casp3↑, 11,   Casp6↑, 1,   Casp7↓, 1,   Casp7↑, 5,   cl‑Casp7↑, 1,   Casp8↓, 1,   Casp8↑, 12,   cl‑Casp8↑, 2,   Casp9↑, 20,   cl‑Casp9↑, 7,   cFLIP↓, 1,   Cyt‑c↓, 1,   Cyt‑c↑, 24,   Cyt‑c↝, 1,   Diablo↑, 3,   DR5↑, 6,   FADD↑, 3,   Fas↑, 10,   FasL↑, 4,   FasL⇅, 1,   GSDME-N↑, 1,   IAP1↓, 2,   ICD↑, 1,   iNOS↓, 1,   Mcl-1↓, 8,   MDM2↓, 3,   NAIP↓, 2,   p38↓, 1,   p‑p38↑, 2,   PUMA↑, 1,   Pyro↑, 1,   survivin↓, 7,   TRAIL↑, 2,   TRAILR↑, 1,   TumCD↑, 2,   XIAP↓, 3,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt?, 1,   Akt↓, 25,   Akt↑, 2,   p‑Akt↓, 12,   AKT1↓, 1,   Akt2↓, 1,   AMPKα↓, 1,   p‑cMET↑, 1,   EGFR↓, 5,   p‑EGFR↓, 2,   ERK↓, 7,   ERK↑, 1,   p‑ERK↓, 2,   FOXD3↑, 1,   HER2/EBBR2↓, 2,   IGF-1R↓, 2,   IGF-1R↑, 1,   IGFR↓, 1,   IKKα↓, 1,   IKKα↑, 1,   IκB↓, 1,   JNK↑, 3,   p‑JNK↑, 1,   MAPK↓, 5,   MAPK↑, 1,   MEK↓, 2,   mTOR↓, 12,   mTOR↑, 1,   p‑mTOR↓, 2,   p70S6↑, 1,   P70S6K↓, 3,   PDGFRB↓, 1,   PI3K↓, 17,   PI3K↑, 1,   p‑PI3K↓, 4,   PI3K/Akt↓, 2,   PIK3CA↓, 1,   PKA↓, 1,   PKCδ↓, 2,   PP2A↑, 1,   PRAS40↓, 1,   PRAS40↑, 1,   PTEN↓, 1,   PTEN↑, 2,   RAS↓, 1,   Sp1/3/4↓, 1,   Src↓, 1,   STAT3↓, 5,   p‑STAT3↓, 1,   STAT5↓, 1,   THEM4/CTMP↑, 1,   TSC2↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

ATF4↓, 1,   ATF4↑, 3,   cJun↓, 2,   p‑cJun↑, 1,   cMyc↓, 2,   FOXO3↓, 1,   FOXO3↝, 1,   GATA3↑, 1,   HATs↓, 1,   HDAC↓, 1,   HDAC1↓, 1,   HDAC2↓, 1,   HDAC3↓, 2,   HOXB-AS1↓, 1,   miR-148a↓, 1,   miR-155↓, 1,   miR-19b↓, 1,   miR-21↓, 1,   Myc↓, 4,   OCT4↓, 1,   other↝, 1,   TBX3↑, 1,   tumCV↓, 8,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↑, 5,   eIF2α↓, 1,   eIF2α↑, 1,   p‑eIF2α↑, 1,   ER Stress↑, 5,   GRP78/BiP↑, 1,   HSP27↓, 1,   HSP27↑, 1,   HSP70/HSPA5↓, 3,   HSP90↓, 2,   PERK↑, 2,   UPR↑, 3,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG13↑, 1,   ATG16L1↑, 1,   ATG3↑, 1,   ATG5↑, 2,   ATG7↑, 1,   Beclin-1/ATG6↑, 4,   p‑Beclin-1/ATG6↑, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 1,   LC3B↑, 1,   LC3II↑, 2,   p62↑, 2,   RUBCN↓, 1,   TumAuto↑, 6,   ULK1/ATG1↑, 2,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↑, 9,   hTERT/TERT↓, 2,   NKX3.1↑, 1,   P53↓, 1,   P53↑, 14,   PARP↑, 7,   cl‑PARP↑, 18,   PCNA↓, 3,   RAD51↓, 1,   Telomerase↓, 2,   TP53↓, 1,   γH2AX↑, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

CDK1↓, 3,   CDK2↓, 5,   CDK4↓, 5,   CDK4↑, 1,   p‑CHK1↓, 1,   Chk2↓, 1,   ChrCon↑, 1,   cycA1/CCNA1↓, 4,   CycB/CCNB1↓, 6,   cycD1/CCND1↓, 9,   cycD1/CCND1↑, 1,   cycE/CCNE↓, 1,   cycE1↓, 1,   E2Fs↓, 1,   Ki-67↓, 2,   P21↑, 11,   p27/CDKN1B↑, 6,   PLK1↓, 1,   Securin↓, 1,   TumCCA↓, 2,   TumCCA↑, 25,   WEE1↑, 2,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

4E-BP1↓, 1,   cFos↓, 2,   CSCs↓, 1,   FGF↓, 1,   Gli1↓, 1,   IGF-1↓, 1,   IGF-2↓, 1,   IGFBP3↑, 1,   Ki-67↓, 2,   mTORC1↓, 2,   NOTCH↓, 1,   NOTCH1↓, 1,   NOTCH3↓, 1,   SCF↓, 1,   Smo↓, 1,   TumCG↓, 6,   TumCP↓, 24,   Wnt↓, 3,   Wnt↑, 1,   Wnt/(β-catenin)↓, 1,  

Migration(tgid=13) ⓘ

APC↑, 1,   Ca+2↑, 6,   Ca+2↝, 1,   E-cadherin↓, 1,   E-cadherin↑, 6,   EMT↓, 4,   EpCAM↓, 1,   FAK↓, 1,   Fibronectin↓, 2,   LEF1↓, 1,   LRP1↓, 1,   MET↓, 1,   MMP-10↓, 1,   MMP1↓, 1,   MMP2↓, 11,   MMP3↓, 2,   MMP7↓, 3,   MMP9↓, 8,   MMPs↓, 2,   MTA1↓, 1,   N-cadherin↓, 5,   RECK↑, 1,   SDC1↑, 1,   Slug↓, 1,   SMAD4↓, 1,   Snail↓, 4,   TGF-β↓, 2,   TIMP1↑, 2,   TIMP2↓, 1,   TIMP2↑, 2,   TSC1↑, 1,   TumCI↓, 4,   TumCMig↓, 7,   TumMeta↓, 5,   Twist↓, 1,   uPA↓, 4,   uPAR↓, 1,   Vim↓, 4,   Zeb1↓, 2,   Zeb1↑, 1,   α-tubulin↑, 1,   β-catenin/ZEB1↓, 2,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 6,   eNOS↓, 1,   HIF-1↓, 1,   Hif1a↓, 6,   VEGF↓, 12,   VEGFR1↓, 2,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 1,   EPR↑, 1,   GLUT1↓, 1,   GLUT2↓, 1,   MMP?, 1,   MMP↓, 22,   MMP↑, 1,   MPT↑, 1,   TRPM7↓, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD44↓, 1,   COX2/PTGS2↓, 4,   CXCR4↑, 1,   IL1β↓, 1,   IL6↓, 2,   IL8↓, 1,   Imm↑, 1,   Inflam↓, 2,   NF-kB↓, 18,   NF-kB↑, 1,   p65↓, 2,   PD-L1↓, 2,   PD-L1↑, 1,   PGE2↓, 2,   PSA↓, 1,   TCF↑, 1,   TLR4↓, 1,   TNF-α↓, 3,   TNF-α↑, 1,   TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, 3,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

AR↓, 1,   PPARγ↑, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

ABCG2↓, 1,   BioAv↓, 3,   BioAv↑, 3,   BioEnh↑, 1,   ChemoSen↑, 10,   CompStab↑, 2,   CompStab↝, 1,   Dose?, 1,   Dose↝, 3,   eff↓, 6,   eff↑, 6,   eff↝, 1,   Half-Life↓, 1,   Half-Life↝, 1,   P-gp/ABCB1↓, 1,   RadioS↑, 4,   selectivity↑, 11,   Synergy↑, 5,  

Clinical Biomarkers(tgid=22) ⓘ

AR↓, 1,   EGFR↓, 5,   p‑EGFR↓, 2,   HER2/EBBR2↓, 2,   hTERT/TERT↓, 2,   IL6↓, 2,   Myc↓, 4,   PD-L1↓, 2,   PD-L1↑, 1,   PSA↓, 1,   TP53↓, 1,   Tumccf↓, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiCan↑, 6,   antiNeop↑, 1,   AntiTum↑, 3,   chemoP↑, 1,   chemoPv↑, 1,   hepatoP↑, 1,   toxicity↓, 3,   TumVol↓, 1,  
Total Targets: 380

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↑, 9,   Catalase↑, 5,   GPx↑, 3,   GSH↑, 4,   GSTs↑, 2,   lipid-P↓, 1,   MDA↓, 1,   MPO↓, 1,   NRF2↑, 2,   RNS↓, 1,   ROS↓, 13,   SOD↓, 1,   SOD↑, 7,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

ALAT↓, 1,   glucose↓, 1,   LDHA↑, 1,   LDL↓, 1,  

Cell Death(tgid=5) ⓘ

Apoptosis↓, 2,   BAD↓, 3,   BAX↓, 4,   Bcl-xL↑, 1,   Casp3↓, 3,   Casp8↓, 1,   Cyt‑c↓, 1,   iNOS↓, 1,   p38↑, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

p‑Akt↑, 2,   p‑ERK↑, 1,   MAPK↓, 1,   p‑mTOR↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

AntiThr↑, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

HSP70/HSPA5↑, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

Beclin-1/ATG6↓, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↓, 1,  

Migration(tgid=13) ⓘ

AntiAg↑, 1,   Ca+2?, 1,   Ca+2↓, 2,   MMP9↓, 1,   PAI-1/SERPINE1↓, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

HIF-1↓, 1,   NO↓, 1,   VEGF↑, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 1,   CLDN1↓, 1,   OCLN↓, 1,   TJ↑, 1,   ZO-1↓, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

COX2/PTGS2↓, 1,   IL1β↓, 1,   IL2↑, 1,   IL6↓, 2,   Inflam↓, 7,   NF-kB↓, 3,   TNF-α↓, 2,  

Synaptic & Neurotransmission(tgid=18) ⓘ

Ach↑, 1,   AChE↓, 1,   ChAT↑, 1,   MAOA↓, 1,  

Protein Aggregation(tgid=19) ⓘ

Aβ↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 2,   BioAv↑, 1,   CompStab↑, 1,   Dose↝, 1,   eff↑, 1,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 1,   AST↓, 1,   BP↓, 1,   BUN↓, 1,   IL6↓, 2,  

Functional Outcomes(tgid=23) ⓘ

AntiArt↑, 3,   AntiCan↑, 2,   antiD↓, 1,   AntiDiabetic↑, 1,   antiPs↑, 1,   cardioP↑, 4,   chemoP↑, 1,   cognitive↑, 1,   hepatoP↑, 3,   memory↑, 2,   neuroP?, 1,   neuroP↑, 8,   Pain↓, 1,   RenoP↑, 1,   Stroke↓, 1,   toxicity↓, 1,   toxicity↝, 1,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 1,   AntiViral↑, 1,   Bacteria↓, 3,   Sepsis↓, 1,  
Total Targets: 90

Scientific Paper Hit Count for: BAD, BCL2 associated agonist of cell death
4 Quercetin
4 Fisetin
3 Curcumin
3 EGCG (Epigallocatechin Gallate)
3 Eugenol
2 Berberine
2 Docetaxel
2 Gambogic Acid
2 Licochalcone A
2 Magnolol
2 Magnetic Fields
2 Morin
1 1,8-Cineole
1 Ashwagandha(Withaferin A)
1 immunotherapy
1 Baicalein
1 Betulinic acid
1 Benzyl isothiocyanate
1 Beetroot
1 α-Bisabolol / Chamomile oil
1 Carvacrol
1 Thymol-Thymus vulgaris
1 Chrysin
1 Cinnamon
1 Crocetin
1 Carvone
1 Docosahexaenoic Acid
1 D-limonene
1 Citric Acid
1 Gallic acid
1 Hibiscus sabdariffa
1 Helleborus niger extracts – Christmas Rose
1 Hyperoside
1 Indole-3-carbinol
1 Juglone
1 Kaempferol
1 low dose naltrexone
1 Licorice
1 Luteolin
1 doxorubicin
1 Mangiferin
1 Melatonin
1 Mushroom Lion’s Mane, Hericium erinaceus
1 Nimbolide
1 Oleuropein
1 HydroxyTyrosol
1 Propyl gallate
1 Piperine
1 Paclitaxel/Taxol
1 Arctigenin
1 α-Santalol/Sandalwood oil
1 Selenite (Sodium)
1 Aflavin-3,3′-digallate
1 triptolide
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:426  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page